Form 4: Progyny President's Routine Tax-Related Stock Sale

Progyny's President, Michael E. Sturmer, reported a disposition of 33,028 shares of common stock for tax withholding purposes.

Summary

• Michael E. Sturmer, President of Progyny, Inc., disposed of 33,028 shares of common stock.
• The transaction occurred on December 31, 2025, at a price of $25.84 per share.
• These shares were withheld for the payment of withholding taxes upon the vesting of restricted stock units granted to Mr. Sturmer.
• Following this transaction, Mr. Sturmer beneficially owns 255,205 shares of Progyny common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was a pre-scheduled event.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction for tax withholding purposes upon RSU vesting, which is neutral in sentiment. It reflects standard executive compensation practices rather than a change in company fundamentals or outlook.

Positives

• The transaction is a routine tax withholding event, indicating the vesting of previously granted restricted stock units, which can be seen as a positive for executive compensation and retention.

Negatives

• No direct negatives are identified as this is a standard tax-related transaction.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and tax obligations, which is a common occurrence across all industries for publicly traded companies when restricted stock units vest. It does not provide specific insights into broader industry trends for fertility benefits or healthcare technology.

Comparison to Industry Standards

• This is a standard tax withholding transaction upon RSU vesting, common for executives across publicly traded companies.
• It aligns with typical compensation structures and tax compliance practices seen in companies like Teladoc Health (TDOC) or Livongo Health (LVGO, prior to acquisition), where executives receive equity compensation that vests over time, leading to similar tax-related dispositions.

Related Party Transactions

• No related party transactions beyond the executive's compensation-related stock activity are disclosed.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary tax-related sale of a small portion of an executive's holdings, not indicative of a change in confidence.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• No specific future actions, events, or milestones are mentioned in this filing.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares for tax withholding purposes upon the vesting of restricted stock units. Such transactions are standard for executive compensation and do not reflect a change in the company's operational performance, financial health, or the executive's confidence in the company. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance is maintained based on existing company fundamentals.

Keywords

Progyny, PGNY, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation, Michael Sturmer